Matthias Vogt

Matthias Vogt is an experienced financial executive with a diverse career in global companies. He served as the Chief Financial Officer at SHL Group (Scandinavian Health Limited), where he drove substantial value creation and growth, leading to a successful exit following EQT's investment.2

Prior to his role at SHL Group, Matthias held several notable positions:

• Chief Financial Officer at Stallergenes Greer, a biopharmaceutical company specializing in respiratory allergy treatments1
• Managing Director at Axalta Coating Systems, a global paint and coatings company1
• Chief Financial Officer at Merz Pharma, where he led the Group's Finance, Legal, and M&A functions1
• Various CFO positions at Novartis across different regions and functions12
• Chief Financial Officer and Executive Director at African Oxygen Limited from 2017 to 20203

Currently, Matthias Vogt serves as the Chief Executive Officer a.i. and Chief Financial Officer at Biosynth, a global life sciences reagents and manufacturing services group.2

Matthias Vogt's educational background includes degrees from prestigious institutions such as WHU – Otto Beisheim School of Management, Harvard Business School, Justus Liebig University Giessen, and the University of Mannheim.2 He also holds a Diploma in Business and Administration from Rosenheim University of Applied Sciences.3